Company: SVREW
Filing Date: 2025-04-03
Form Type: 424B3
Source: 0001213900-25-028394
Chunk: 4

Company: SaverOne 2014 Ltd.
Filing Date: 2025-04-03
Form: 424B3
Chunk 4
---
 herein. See “Plan of Distribution.”

See the section titled “The
Yorkville Transaction” for a description of the transaction contemplated by the SEPA and “Selling Shareholder” for
additional information regarding Yorkville.

As of the date of this Prospectus, we received approximately $5.84
million in aggregate proceeds pursuant to Advances under the SEPA. The amount that we may receive under the SEPA in the future is difficult
to estimate depends on a number of factors, including the Conversion Price, the frequency and prices at which we issue ADSs to Yorkville,
market conditions and the trading price of our Ordinary Shares, our ability to meet the conditions set forth in the SEPA, and determinations
by us as to the appropriate sources of funding for our company and our operations.

Yorkville is an “underwriter”
within the meaning of Section 2(a)(11) of the Securities Act of 1933, as amended (the “Securities Act”),
and any profits on the sales of shares of our ADSs by Yorkville and any discounts, commissions, or concessions received by Yorkville
are deemed to be underwriting discounts and commissions under the Securities Act.

Our ordinary shares are listed
on the Tel Aviv Stock Exchange Ltd., or the TASE, under the symbol “SVRE.” The last reported sale price of our ordinary shares
on the TASE on March 30, 2025, was NIS 0.01 or $0.0027 per share (based on the exchange rate reported by the Bank of Israel on that date,
which was NIS 3.684 = $1.00).

Our ADSs are listed on the
Nasdaq Capital Market, or Nasdaq, under the symbol “SVRE. The last reported sale price of our ADSs on Nasdaq on March 28, 2025,
was $3.215 per ADS.

We may amend or supplement
this prospectus from time to time by filing amendments or supplements as required. You should read this entire prospectus and any amendments
or supplements carefully before you make your investment decision.

We are both an “emerging
growth company” as defined in the Jumpstart Our Business Startups Act of 2012, or the JOBS Act, and, a “foreign private issuer,”
as defined under the U.S. federal securities laws, and as such, are eligible for reduced public company reporting requirements. See “Prospectus
Summary—Implications of Being an Emerging